Developing A Novel Low-Cost RFID System for Increasing Hand Hygiene Compliance among Healthcare Workers in an ICU: Methodology
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2013 - 2013
Project Lead
Dr. Tony Raj, Dr. Sriram Sampath, Dr. Kedar Radhakrishna
Authors
Dr. Tony Raj, Dr. Sriram Sampath, Dr. Kedar Radhakrishna
Project Status
completed
Project Type
University of California at San Francisco, USA